en POLSKI
eISSN: 2084-9834
ISSN: 0034-6233
Reumatologia/Rheumatology
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank


Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
3/2008
vol. 46
 
Share:
Send email
Share:
abstract:

REVIEW PAPER
Adalimumab – the first fully human monoclonal antibody used in the treatment of rheumatoid arthritis

Jacek Szechiński
,
Sławomir Jeka
,
Krzysztof Borysewicz
,
Anna Filipowicz-Sosnowska
,
Katarzyna Kolossa
,
Eugeniusz J. Kucharz
,
Beata Nowak
,
Jerzy Świerkot
,
Piotr Wiland

Reumatologia 2008; 46, 3: 151–158
Online publish date: 2008/07/09
View full text Get citation
 
Rheumatoid arthritis is a systemic inflammatory disease leading to joint deformation and multiorgan dysfunction. Adalimumab belongs to a new class of antirheumatic drugs. This article gives a systematic review of data supporting the efficacy of adalimumab in the treatment of rheumatoid arthritis.
keywords:

adalimumab, rheumatoid arthritis
EVENTS/KONFERENCJE
BOOKS/KSIĄŻKI



Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.